Hill-Rom, Inc. – FDA Warning Letter, Jun 21, 2007

On January 15, 2008, the FDA issued a Warning Letter to Hill-Rom, Inc. following an inspection from May 29 to June 21, 2007, which found their VersaCare Beds (models P3200 and P3201) to be adulterated and misbranded.

The inspection revealed significant violations of Current Good Manufacturing Practice (CGMP) requirements under 21 CFR Part 820 (Quality System Regulation) and 21 CFR Parts 803 and 806 (Medical Device Reporting and Reports of Corrections and Removals).

Key violations include: 1. **Failure to establish and maintain corrective and preventive action (CAPA) procedures (21 CFR 820.100(a)):** Hill-Rom failed to fully implement CAPA00825, a design modification for an unacceptable latch failure rate. Despite redesigning the latching mechanism, only a portion of the affected 10,000 global units were corrected, with the firm initially classifying the issue as a "customer satisfaction issue" rather than a potential health hazard. While a proposed correction plan for all affected devices was later submitted, the initial response was deemed inadequate. 2. **Failure to establish and maintain adequate complaint handling procedures (21 CFR 820.198(c)):** The firm marked numerous complaints